The invention relates to an electronic device containing at least one compound of formula (I) or (II) in an organic layer. The invention further relates to a method for producing the electronic device and the use of a compound of formula (I) or (II) in an electronic device.

Processes of polymerizing olefins. The process includes polymerizing contacting ethylene and a (C.sub.3-C.sub.40)alpha-olefin comonomer in the presence of a catalyst system comprising a procatalyst and a bimetallic activator complex. The bimetallic activator complex includes an anion and a countercation. The anion having a structure according to formula (I).

The invention relates to silane compounds of the general formula (I) as defined herein containing at least one heteroatom bridged to a silicon atom via a sp.sup.2-hybridized quaternary carbon atom, a process for preparing the silane compounds, and the use of the silane compounds as end-capping agent, crosslinker, and/or adhesion promoter in curable compositions.

Disclosed are a compound for an organic optoelectronic device represented by Chemical Formula 1, a composition for an organic optoelectronic device including the same, an organic optoelectronic device, and a display device.

Details of Chemical Formula 1 are as defined in the specification.

The present application relates to a polycyclic compound including nitrogen and an organic light emitting device including the same.

The present invention relates to a plurality of host materials and an organic electroluminescent device comprising the same. By comprising a specific combination of a plurality of host compounds, the organic electroluminescent device according to the present invention provides high efficiency and a long lifespan.

A light-emitting device including a heterocyclic compound represented by Formula 1 or 2, an electronic apparatus including the light-emitting device, and the heterocyclic compound represented by Formula 1 or Formula 2:

##STR00001##

wherein the detailed description of Formulae 1 and 2 is the same as described in the present specification.

Heterocyclic compounds of formula (I), methods for their preparation, pharmaceutical compositions containing such a compound and their therapeutic uses.

There are provided compounds of formula I, (I): ##STR00001## wherein R.sup.1 to R.sup.5, X.sup.1, X.sup.2, Ar, L, E, A, A1, G and G.sup.1 have meanings given in the description, which compounds have anti-inflammatory activity (e.g., through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; Syk kinase; and members of the Src family of tyrosine kinases) and have use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines.

A ligand compound having a novel structure, a transition metal compound including the same, a catalyst composition including the transition metal compound, and a method of preparing an olefin polymer using the catalyst composition are disclosed herein. In some embodiments, the transition metal compound is represented by Formula 1. In some embodiments, the ligand compound is represented by Formula 2.